First Quadrant’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-16,532
| Closed | -$976K | – | 416 |
|
|
2021
Q4 | $976K | Sell |
16,532
-239
| -1% | -$11.8K | 0.11% | 168 |
|
|
2021
Q3 | $721K | Buy |
16,771
+239
| +1% | +$10.6K | 0.08% | 205 |
|
|
2021
Q2 | $647K | Sell |
16,532
-3,638
| -18% | -$141K | 0.07% | 223 |
|
|
2021
Q1 | $731K | Sell |
20,170
-1,561
| -7% | -$55.4K | 0.08% | 201 |
|
|
2020
Q4 | $800K | Sell |
21,731
-8,073
| -27% | -$296K | 0.08% | 182 |
|
|
2020
Q3 | $1.04M | Sell |
29,804
-36,677
| -55% | -$1.29M | 0.13% | 143 |
|
|
2020
Q2 | $2.06M | Buy |
66,481
+34,295
| +107% | +$1.17M | 0.28% | 92 |
|
|
2020
Q1 | $997K | Sell |
32,186
-993
| -3% | -$33.8K | 0.15% | 163 |
|
|
2019
Q4 | $1.23M | Sell |
33,179
-593
| -2% | -$21.1K | 0.1% | 198 |
|
|
2019
Q3 | $1.15M | Sell |
33,772
-6,372
| -16% | -$232K | 0.11% | 197 |
|
|
2019
Q2 | $1.65M | Sell |
40,144
-57
| -0.1% | -$2.26K | 0.11% | 216 |
|
|
2019
Q1 | $1.62M | Sell |
40,201
-21,369
| -35% | -$856K | 0.12% | 176 |
|
|
2018
Q4 | $2.55M | Sell |
61,570
-949,769
| -94% | -$39.4M | 0.21% | 110 |
|
|
2018
Q3 | $42.3M | Buy |
1,011,339
+11,794
| +1% | +$454K | 0.94% | 9 |
|
|
2018
Q2 | $34.4M | Sell |
999,545
-138,489
| -12% | -$4.73M | 0.64% | 25 |
|
|
2018
Q1 | $38.3M | Buy |
1,138,034
+913,358
| +407% | +$31.4M | 0.73% | 14 |
|
|
2017
Q4 | $7.72M | Buy |
224,676
+13,598
| +6% | +$464K | 0.14% | 196 |
|
|
2017
Q3 | $7.15M | Sell |
211,078
-5,702
| -3% | -$183K | 0.14% | 208 |
|
|
2017
Q2 | $6.91M | Sell |
216,780
-7,746
| -3% | -$244K | 0.14% | 208 |
|
|
2017
Q1 | $7.29M | Sell |
224,526
-6,648
| -3% | -$210K | 0.14% | 206 |
|
|
2016
Q4 | $7.12M | Sell |
231,174
-269,028
| -54% | -$8.21M | 0.15% | 207 |
|
|
2016
Q3 | $16.1M | Sell |
500,202
-15,031
| -3% | -$503K | 0.34% | 92 |
|
|
2016
Q2 | $17.2M | Sell |
515,233
-1,165,408
| -69% | -$37.2M | 0.38% | 85 |
|
|
2016
Q1 | $47.3M | Sell |
1,680,641
-84,209
| -5% | -$2.41M | 1.03% | 12 |
|
|
2015
Q4 | $54.1M | Sell |
1,764,850
-104,446
| -6% | -$3.29M | 1.19% | 9 |
|
|
2015
Q3 | $55.7M | Buy |
1,869,296
+208,375
| +13% | +$6.68M | 1.24% | 12 |
|
|
2015
Q2 | $52.8M | Buy |
1,660,921
+527
| +0% | +$17.2K | 1.11% | 14 |
|
|
2015
Q1 | $54.8M | Sell |
1,660,394
-367,635
| -18% | -$11.7M | 1.14% | 13 |
|
|
2014
Q4 | $59.9M | Sell |
2,028,029
-4,532
| -0.2% | -$130K | 1.26% | 10 |
|
|
2014
Q3 | $57M | Buy |
2,032,561
+422
| +0% | +$11.8K | 1.28% | 10 |
|
|
2014
Q2 | $57.2M | Buy |
2,032,139
+81,052
| +4% | +$2.31M | 1.27% | 9 |
|
|
2014
Q1 | $59.5M | Buy |
1,951,087
+38,787
| +2% | +$1.16M | 1.35% | 9 |
|
|
2013
Q4 | $55.6M | Buy |
1,912,300
+57,022
| +3% | +$1.66M | 1.3% | 9 |
|
|
2013
Q3 | $50.6M | Sell |
1,855,278
-16,653
| -0.9% | -$453K | 1.28% | 7 |
|
|
2013
Q2 | $49.7M | Buy |
+1,871,931
| New | +$51.7M | 1.33% | 7 |
|
Other funds holding PFE
First Quadrant's PFE Position: Q1 2022 in Review
First Quadrant sold out of Pfizer (PFE) in Q1 2022, closing a stake of 16,532 shares — an estimated $976K sold.
First Quadrant first reported a position in PFE in Q2 2013 and held it in 35 quarters. The position peaked at $59.9M in Q4 2014. 3,196 funds tracked by Wall St. Rank hold PFE as of Q1 2022.
- First Quadrant reported no remaining Pfizer position as of Q1 2022 after selling out during the quarter.
- First Quadrant sold 16,532 Pfizer shares in Q1 2022, an estimated $976K.
- First Quadrant first reported a position in Pfizer in Q2 2013 and held it in 35 quarters.
- First Quadrant's Pfizer position peaked at $59.9M in Q4 2014.
- 3,196 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.
Based on First Quadrant's 13F filing for Q1 2022, filed 21 Apr 2022.